abstract |
(I) Compounds of formula I or salts thereof are disclosed wherein: X is CR < 6 > or N; W is: (i) - (CR 3 R 3 ) 1-4 - or (ii) - (CR 3 R 3 ) x -Y- (CR 3 R 3 ) y -; Y, R 1 , R 2 , R 3 , R 5 , R 6 , R 7 , x, and y are defined herein. Methods of using such compounds as modulators of TNFa, and pharmaceutical compositions comprising such compounds, are also disclosed. These compounds are useful for treating inflammatory and autoimmune diseases. |